Treace Medical Concepts Inc (TMCI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Treace Medical Concepts Inc (TMCI) has a cash flow conversion efficiency ratio of 0.094x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($7.23 Million) by net assets ($77.19 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Treace Medical Concepts Inc to measure how much of total assets are equity-financed.
Treace Medical Concepts Inc - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how Treace Medical Concepts Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Treace Medical Concepts Inc to evaluate the quality of earnings relative to operating cash generation.
Treace Medical Concepts Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Treace Medical Concepts Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Korea Electronic Power Industrial Development Co Ltd
KO:130660
|
-0.020x |
|
Total Bangun Persada Tbk
JK:TOTL
|
0.158x |
|
Síminn hf
IC:SIMINN
|
0.082x |
|
Amazing Microelectronic
TWO:6411
|
0.030x |
|
NXG NextGen Infrastructure Income Fund
NYSE:NXG
|
0.768x |
|
centrotherm international AG
F:CTNK
|
0.077x |
|
Flexsteel Industries Inc
NASDAQ:FLXS
|
0.119x |
|
Spok Holdings Inc
NASDAQ:SPOK
|
0.017x |
Annual Cash Flow Conversion Efficiency for Treace Medical Concepts Inc (2019–2025)
The table below shows the annual cash flow conversion efficiency of Treace Medical Concepts Inc from 2019 to 2025. For the full company profile with market capitalisation and key ratios, see TMCI market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $87.33 Million | $-15.97 Million | -0.183x | +44.46% |
| 2024-12-31 | $112.89 Million | $-37.17 Million | -0.329x | -31.35% |
| 2023-12-31 | $137.94 Million | $-34.58 Million | -0.251x | +50.50% |
| 2022-12-31 | $60.53 Million | $-30.65 Million | -0.506x | -174.10% |
| 2021-12-31 | $93.07 Million | $-17.19 Million | -0.185x | +96.81% |
| 2020-12-31 | $776.00K | $-4.49 Million | -5.791x | -138.58% |
| 2019-12-31 | $3.16 Million | $-7.67 Million | -2.427x | -- |
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D M… Read more